Market Insight - How to manage clinical grant costs
This article was originally published in Scrip
Clinical trial sponsors understand the strategic importance of containing costs. But are they paying enough attention to the clinical grant management function? Dr Harold E Glass and Karen Hollander discuss.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.